Eli Lilly
Eli Lilly develops and manufactures medicines for diabetes, obesity, cancer and other diseases.
Live Healthcare
Market Monitors
SANOR’s Market Monitors consolidate company announcements, financial reporting and industry developments into a source-linked view of healthcare markets, their participants and their commercial activity.
Market Size Tracked
$79.0bn
Sum of reported market sizes. Markets may overlap.
Companies Tracked
8
Companies in our market intelligence library.
Ticker Activity
22
Last 12 months
Deal Activity
7
Last 12 months
Recent activity covers the past 30 days.
Novo Nordisk
Novo Nordisk develops and manufactures medicines for diabetes and obesity, including Ozempic and Wegovy (semaglutide).
MannKind
MannKind develops inhaled drug-delivery technology, including its Technosphere platform.
Revvity
Revvity supplies tools and services for life sciences research and diagnostics.
Roche
Roche is a healthcare company headquartered in Basel, Switzerland, with businesses in pharmaceuticals and diagnostics.
Superluminal
Superluminal develops investigational medicines, including an obesity program targeting MC4R.
Hims & Hers
Hims & Hers provides weight-management consultations, prescriptions and ongoing care through its telehealth platforms.
Poolbeg Pharma
Poolbeg Pharma develops investigational treatments and is funding an oral GLP-1 proof-of-concept trial alongside its POLB 001 TOPICAL trial.
